Literature DB >> 20919392

Pharmacokinetic studies of cefuroxime and dosage recommendations in patients with impaired renal function.

D Höffler, M Sassmann.   

Abstract

Entities:  

Year:  1977        PMID： 20919392      PMCID： PMC1543240     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  3 in total

1.  Cephaloridine and cephalothin: comparative studies of potential nephrotoxicity.

Authors:  R L Perkins; M A Apicella; I S Lee; F E Cuppage; S Saslaw
Journal:  J Lab Clin Med       Date:  1968-01

2.  [Blood levels of cephalothin in normal and impaired renal function].

Authors:  D Höffler; P Koeppe; E Fuchs; P Fiegel
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1972-02

3.  Reversible encephalopathy following cephacetril therapy in high doses in a patient on chronic intermittent hemodialysis.

Authors:  G Heinecke; U Höffler; K Finke
Journal:  Clin Nephrol       Date:  1976-01       Impact factor: 0.975
  3 in total
  4 in total

Review 1.  Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

3.  Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays.

Authors:  R W Bundtzen; R D Toothaker; O S Nielson; P O Madsen; P G Welling; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

4.  Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency.

Authors:  R A Walstad; O G Nilsen; K J Berg
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.